Related Experiment Video
Updated: Jul 9, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Primary hypertrophic osteoarthropathy with myelofibrosis
Massoud Saghafi1, Azita Azarian, Najmeh Nohesara
1Department of Rheumatology, Ghaem Hospital, Mashhad University, Mashhad, Iran. SaghafiM@mail.mums.ac.ir
Primary hypertrophic osteoarthropathy (pachydermoperiostosis) is a rare genetic disorder causing skin thickening and bone changes. This case highlights a 43-year-old man with prominent symptoms and associated myelofibrosis.
Area of Science:
- Genetics and rare diseases
- Dermatology
- Rheumatology
Background:
- Primary hypertrophic osteoarthropathy, also known as pachydermoperiostosis, is a rare inherited disorder.
- It typically presents with digital clubbing, periostitis, and skin thickening (pachydermia).
- Manifestations usually appear in young to middle-aged adults.
Observation:
- This report details a 43-year-old male patient with pachydermoperiostosis.
- The patient exhibited significant skin and joint manifestations.
- He also presented with anemia, which prompted further investigation.
Findings:
- Bone marrow biopsy revealed myelofibrosis in the patient.
- This finding suggests a potential link or co-occurrence between pachydermoperiostosis and myelofibrosis.
- The case underscores the complex clinical presentation of this rare condition.
Implications:
- This case expands the known clinical spectrum of primary hypertrophic osteoarthropathy.
- It suggests a possible association between pachydermoperiostosis and hematological disorders like myelofibrosis.
- Further research is warranted to explore the relationship between these conditions.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Myocarditis I: Introduction
Rheumatic Heart Disease I: Introduction
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
